Susquehanna International Group
ASBPW

Susquehanna International Group’s Aspire Biopharma Warrant ASBPW Stock Holding History

Susquehanna International Group’s Portfolio ASBPW Stock Details ASBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$279 Buy
+16,781
New +$342 ﹤0.01% 13053
2025
Q4 		– Sell
-57,932
Closed -$1.73K – 14004
2025
Q3 		$1.73K Buy
+57,932
New +$2.93K ﹤0.01% 12178
2024
Q1 		– Sell
-23,803
Closed -$1.43K – 13585
2023
Q4 		$1.43K Sell
23,803
-2,547
-10% -$105 ﹤0.01% 12187
2023
Q3 		$1.32K Sell
26,350
-7,583
-22% -$612 ﹤0.01% 11868
2023
Q2 		$1.7K Buy
+33,933
New +$1.25K ﹤0.01% 11878

Other funds holding ASBPW

MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group's ASBPW Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Aspire Biopharma Warrant (ASBPW) in Q1 2026: 16,781 shares worth $279. The stake represents ﹤0.01% of the portfolio and ranks #13053 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in ASBPW as recently as Q3 2025.

Susquehanna International Group first reported a position in ASBPW in Q2 2023 and has held it in 5 quarters since. The position peaked at $1.73K in Q3 2025. 29 funds tracked by Wall St. Rank hold ASBPW as of Q1 2026.

  • Susquehanna International Group held 16,781 shares of Aspire Biopharma Warrant worth $279 as of Q1 2026.
  • Aspire Biopharma Warrant was a new Susquehanna International Group position in Q1 2026.
  • Aspire Biopharma Warrant made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #13053 holding.
  • Susquehanna International Group first reported a position in Aspire Biopharma Warrant in Q2 2023 and has held it in 5 quarters since.
  • Susquehanna International Group's Aspire Biopharma Warrant position peaked at $1.73K in Q3 2025.
  • 29 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.